
Expanding the clinical trial portfolio for lung cancer
Matthew Hatton

Anti-HER2 strategies in breast cancer: the ALTTO trial
Matteo Lambertini

An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate
Mark Emberton

Will diffusion-weighted MRI replace PET-CT in lung cancer?
Katsuo Usuda

Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer
Freddie Hamdy